top
Search terms
Results 1 - 10 of 99 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 10
Ehjournal

Abstract Aims To evaluate oral doses of the non-steroidal mineralocorticoid receptor antagonist finerenone given for 90 days in patients with worsening heart failure and reduced ejection fraction and ...

European Heart Journal, Filippatos, Gerasimos, Anker, Stefan D., Böhm, Michael, Gheorghiade, Mihai, Køber, Lars, Krum, Henry, Maggioni, Aldo P., Ponikowski, Piotr, Voors, Adriaan A., Zannad, ...

Date : 14/07/2016 Item size : 336949 bytes
Ehjournal

Abstract Aims To evaluate oral doses of the non-steroidal mineralocorticoid receptor antagonist finerenone given for 90 days in patients with worsening heart failure and reduced ejection fraction and ...

European Heart Journal, Filippatos, Gerasimos, Anker, Stefan D., Böhm, Michael, Gheorghiade, Mihai, Køber, Lars, Krum, Henry, Maggioni, Aldo P., Ponikowski, Piotr, Voors, Adriaan A., Zannad, ...

Date : 14/07/2016 Item size : 384189 bytes
Ehjournal

Causes of dilated cardiomyopathy Dilated cardiomyopathy is currently defined by the presence of left ventricular (LV) or biventricular dilatation and systolic dysfunction in the absence of abnormal ...

European Heart Journal, Pinto, Yigal M., Elliott, Perry M., Arbustini, Eloisa, Adler, Yehuda, Anastasakis, Aris, Böhm, Michael, Duboc, Denis, Gimeno, Juan, de Groote, Pascal, Imazio, Massimo, ...

Date : 14/06/2016
Ehjournal

Table 1 Aetiologies of dilated cardiomyopathy Group Subtype disease or agent Comments  Genetics  Main genes associated with predominant cardiac phenotype:        Titin ...

European Heart Journal, Pinto, Yigal M., Elliott, Perry M., Arbustini, Eloisa, Adler, Yehuda, Anastasakis, Aris, Böhm, Michael, Duboc, Denis, Gimeno, Juan, de Groote, Pascal, Imazio, Massimo, ...

Date : 14/06/2016 Item size : 407936 bytes
Ehjcardiovascrec

Citation Dominik Linz, Mathias Hohl, Stefan Dhein, Sven Ruf, Jan-Christian Reil, Mostafa Kabiri, Paulus Wohlfart, Sander Verheule, Michael Böhm, Thorsten Sadowski, Ulrich Schotten; Cathepsin A ...

Cardiovascular Research, Linz, Dominik, Hohl, Mathias, Dhein, Stefan, Ruf, Sven, Reil, Jan-Christian, Kabiri, Mostafa, Wohlfart, Paulus, Verheule, Sander, Böhm, Michael, Sadowski, Thorsten, ...

Date : 01/06/2016 Item size : 138471 bytes
Ehjcardiovascrec

Introduction Atrial fibrillation (AF) is the most common type of sustained tachyarrhythmia and is associated with significant morbidity and mortality.1 Diabetes is a strong independent risk factor ...

Cardiovascular Research, Linz, Dominik, Hohl, Mathias, Dhein, Stefan, Ruf, Sven, Reil, Jan-Christian, Kabiri, Mostafa, Wohlfart, Paulus, Verheule, Sander, Böhm, Michael, Sadowski, Thorsten, ...

Date : 01/06/2016
Ehjcardiovascrec

Introduction Atrial fibrillation (AF) is the most common type of sustained tachyarrhythmia and is associated with significant morbidity and mortality.1 Diabetes is a strong independent risk factor ...

Cardiovascular Research, Linz, Dominik, Hohl, Mathias, Dhein, Stefan, Ruf, Sven, Reil, Jan-Christian, Kabiri, Mostafa, Wohlfart, Paulus, Verheule, Sander, Böhm, Michael, Sadowski, Thorsten, ...

Date : 01/06/2016 Item size : 334840 bytes
Ehjournal

Not surprisingly in this context, the latest non-drug treatment which triggered controversy is catheter-based renal denervation (RDN).3,4 The method uses radiofrequency energy, or alternatively ...

European Heart Journal, Mahfoud, Felix, Böhm, Michael, Azizi, Michel, Pathak, Atul, Durand Zaleski, Isabelle, Ewen, Sebastian, Tsioufis, Kostantinos, Andersson, Bert, Blankestijn, Peter J., ...

Date : 01/09/2015
Ehjournal

Not surprisingly in this context, the latest non-drug treatment which triggered controversy is catheter-based renal denervation (RDN).3,4 The method uses radiofrequency energy, or alternatively ...

European Heart Journal, Mahfoud, Felix, Böhm, Michael, Azizi, Michel, Pathak, Atul, Durand Zaleski, Isabelle, Ewen, Sebastian, Tsioufis, Kostantinos, Andersson, Bert, Blankestijn, Peter J., ...

Date : 01/09/2015 Item size : 533754 bytes
Ehjournal

The Supplemental Benefit of an Angiotensin Receptor Blocker in Hypertensive Patients with Stable Heart Failure Using Olmesartan (SUPPORT, NCT00417222) trial, a prospective, randomized, open-label ...

European Heart Journal, Ewen, Sebastian, Böhm, Michael

Date : 14/04/2015